RESEARCH ARTICLE


Comparison of Ropivacaine-Fentanyl with Bupivacaine-Fentanyl for Labour Epidural Analgesia



Kalpana Kulkarni1, *, Rahul Patil1
1 Department of Anaesthesiology, D. Y. Patil Medical College Hospital and Research Institute, Kolhapur ( MH), India


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 74
Abstract HTML Views: 15
PDF Downloads: 0
Total Views/Downloads: 89
Unique Statistics:

Full-Text HTML Views: 65
Abstract HTML Views: 14
PDF Downloads: 0
Total Views/Downloads: 79



Creative Commons License
© 2020 Kulkarni & Patil.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Anaesthesiology, D. Y. Patil Medical College Hospital and Research Institute, Kolhapur ( MH), India; Tel: +91-9822065665; E-mails: drkrk29@gmail.com; drrmk@rediffmail.com


Abstract

Background:

Bupivacaine with opioid is commonly used for labour epidural analgesia. Ropivacaine is considered as an alternative to bupivacaine due to its lower cardiovascular complications. However, there is a controversy regarding the efficacy of these drugs as some studies suggest equivalent action, whereas others report that ropivacaine produces less motor blockade. The study aimed to compare the effect of ropivacaine-fentanyl and bupivacaine-fentanyl for labour analgesia.

Materials and Methods:

The prospective randomized study was performed on 60 parturients, divided into two groups of 30 subjects each. Group I received 10ml of bupivacaine 0.1% + fentanyl 2µg/ml and Group II received 10ml of ropivacaine 0.1% + fentanyl 2µg/ml by epidural catheter. Pre-anaesthetic evaluation was performed on all the participants and all were administered metoclopramide 0.25mg/kg and ondansetron 0.08-0.1mg/kg intravenously as premedication. The baseline and post anaesthesia systolic, diastolic blood pressure, heart rate, VAS score, degree of motor block, sedation and APGAR score of the baby were recorded. The data were tabulated and statistically analyzed.

Results:

When compared, there was no significant difference in systolic/diastolic blood pressure in two groups except at 360 min where diastolic pressure was low in group II. Significantly higher heart rate at 30 min (P=0.0003), 120 min (0.006), and 300 min (P=0.001) was observed in group I subjects. VAS score was significantly less at 180 min (P=0.019) and 300 min (P=0.019) in group II. Adverse effects such as fetal bradycardia, nausea/vomiting and hypotension observed were clinically insignificance when compared in two groups.

Conclusion:

Bupivacaine and ropivacaine produce an equal degree of analgesia and hemodynamic stability in 0.1% of concentration when added with 2µg/ml fentanyl . However, heart rate was well maintained with lower VAS scores in group II receiving ropivacaine. No significant difference in the side effects between the two groups. Hence, Ropivacaine can be used as a safe alternative to bupivacaine for labour epidural analgesia.

Keywords: Labour pain, Bupivacaine, Ropivacaine, Fentanyl, Epidural Analgesia, Pain relief.



1. INTRODUCTION

Maternal stress response induced by labour pain is neither beneficial for the mother nor for the foetus [1] Inability to bear the pains of labour is one of the reasons for elective caesarean sections [2, 3]. Additionally, it causes maternal sympathetic activation leading to uncoordinated uterine activity and compromises the foetal oxygenation. Hence, pain relief is important in preventing maternal and perinatal morbidity and reducing the chances of caesarean section due to maternal anxiety [4]. Neuroaxial technique of epidural analgesia is the most popular and effective method of pain relief in labour [5]. The major advantages are no risk of gastric aspiration, avoidance of depressant general anaesthetic drugs and allows the mother to be awake to participate in the delivery. Ideal analgesic drugs should have a long duration of action with less motor blockade, limited perinatal transfer, and no adverse effects on the mother and fetus. So combination of opiods with Local Anaesthetic (LA) was shown to be more effective compared with LA alone [6, 7]. For this reason, LA bupivacaine is commonly used. Despite wide spread utility and relative safety of bupivacaine, ropivacaine and levobupivacaine were developed to decrease cardiac risks and CNS toxicity. Moreover, these agents cause less motor blockade compared to bupivacaine. Ropivacaine being 40% less potent than bupivacaine and having a tendency for differential blockade, is preferred for labour analgesia [8]. Along with LA, opioids (fentanyl or sufentanil) are used to reduce the dose and adverse effects of the anaesthetic agents [9]. The purpose of the study was to evaluate and compare the effect of bupivacaine –fentanyl and ropivacaine-fentanyl in the control of labour pain, effects on hemodynamics and fetus as well as observe the side effects or complications.

2. MATERIALS AND METHODS

This prospective randomized study was performed at a tertiary care centre in Kolhapur, India, after approval by the Institutional Ethics and Review board (DYPMCK/PG-14/ 1721/15-16). Subjects were allotted to one of the two groups (Group I & II) by computer generated number criteria, each consisting of 30 subjects. On obtaining written informed consent, 60term parturients (primigravida and gravida 2nd or 3rd) of ASA grade I and II, aged between 19-40 years who had mild pregnancy-induced hypertension or requested epidural labour analgesia were included in the sample. Parturients with severe pregnancy-induced hypertension, eclampsia, severe anaemia, previous caesarean section, cephalopelvic disproportion, breech presentation, allergy to anesthetics, bleeding disorders, psychological/neurological disease and severe spine deformities were excluded from the study. All parturients were thoroughly assessed and investigated for routine blood counts, PT-INR, blood sugar, urea, creatinine. Liver function test, uric acid and ECG was done in cases of pre-eclampsia. The treating obstretician monitored the uterine contractions and cervical dilatation and effacement every half an hour or when deemed necessary and informed us for the institution of labour analgesia. With the onset of first stage of labour (having regular painful contractions in latent phase) with cervical dilatation of 3-4 cm epidural analgesia was instituted. Group I patients received 10ml of bupivacaine (0.1%) + fentanyl 2µg/ml and Group II received 10ml of ropivacaine (0.1%) + fentanyl 2µg/ml. Pre-anaesthesia evaluation was performed on all the participants and all were administered metoclopramide 0.25mg/kg and ondansetron 0.08-0.1mg/kg by intravenous route as premedication. The baseline heart rate (HR) systolic blood pressure (SBP) and diastolic blood pressure(DBP) were recorded. Intravenous infusion of ringer’s lactate solution was given following which patients were placed in a flexed sitting or lateral position. The epidural space at L2-3 or L3-4 was identified using an18G Touhy’s needle by “loss of resistance to air” technique. An epidural catheter was inserted through the needle and kept at about 4-5cm inside the epidural space and secured. Administration of 10ml of drug (bupivacaine or ropivacaine) in concentrations of 0.1% with fentanyl 2µg/ml was given to achieve T10-L1 sensory level. Top-up doses (bupivacaine in Group I and ropivacaine in Group II) in concentrations of 0.1%with fentanyl 2µg/ml were given after 1 hour of progression of labour or according to parturient demands, whichever was earliest, till the baby’s delivery. The efficacy of the study drugs was assessed using visual analog scale (VAS scale) along with mother’s vitals like HR,SBP, DBP, were measured every 5 min till 30 min then at 60 min and later every hour for six hours. The degree of motor blockade was assessed using a modified Bromage scale (grade I=complete motor blockade-unable to move feet, knees and hip flexion, grade II= able to move feet only, grade III=partial block-just able to move knees, grade IV=detectable weakness in hip flexion but full flexion of knees, grade V =no detectable weakness of hip flexion)and sedation score with four point sedation scale (1=awake, 2=asleep, brisk response to verbal command, 3=asleep, sluggish response to verbal command, 4=deeply sedated) every one hourly after institution of labour analgesia and upto six hours post delivery. Post-delivery APGAR score was assessed at 1, 2, 3 and 5 minutes. Baby was monitored for any respiratory distress or neurological symptoms after delivery. Observation of mother was done for any early complications like itching, rash, bradycardia, hypotension, bronchospasm, retention of urine, fever, as well as late complications like postdural pucture headache (PDPH),backache and any neurological symptoms. Vital monitoring was continued of the parturient regularly for 24 hours post-delivery.

3. STATISTICAL ANALYSIS

The sample size was calculated using R Studio V 1.2.5001 software. The calculated sample size was 23 for both the groups and the power of the study was 90%. Data were analyzed using R Studio V 1.2.5001 software. Categorical variable (cervical dilation, VAS score Bromage score, sedation score) were expressed as mean frequency. Whereas continuous variables (demography) were represented in mean±SD. The Students’t-test and Wilcoxon signed rank test was used to find mean difference between variables such as demography, blood pressure and duration of epidural top-up of both the groups. P<0.05 was considered as statistically significant.

Table 1. Demographical characteristics of the patients in Groups I & II.
Demography Group I
Bupivacaine (mean±SD)
Group II
Ropivacaine (mean±SD)
P-value
Age (years) 22.87±3.2 22.23±2.5 0.6372
Height (cm) 152.5±5.08 151.36±6 0.4836
Weight (kg) 68.06±6.93 66.9±6.3 0.4964
Gestational age (weeks) 39.94±0.7 39.45±0.78 0.0191*

4. RESULTS

The demographic characteristics of both groups are shown in Table 1. The characteristics like (age, height and weight) were similar in both the group. However, a significant difference was observed in the gestational age of the subjects (P=0.019, P<0.05).In Group I (60%) and Group II (63%) parturients were primigravida. The dilatation of cervix at which labour analgesia was instituted is shown in Fig. (1). 50% parturients in Group I & 37% parturients in Group II had cervical dilatation 3cm. 30% parturients in both groups had cervical dilatation 4 cm. In Groups I and II, no significant difference was observed in systolic blood pressure at all time intervals. However, a statistically significant difference was observed in diastolic blood pressure at 6 hours (360 min) that was less in Group II than in group I(P=0.02) Table 2. Significantly higher heart rate at 30 min (P=0.0003), 120 min (0.006), and 300 min (P=0.001) was observed in Group I subjects when compared with Group II. VAS score was significantly different between the groups at 180 min and 300 min which was lesser in Group II than in Group I. Table 3. Although a statistically significant difference was seen in the 3rd top-up duration but it was clinically insignificant. Time for epidural top-ups is shown in Fig. (2). In Group I, 87%(n=26) of the parturients had normal vaginal delivery, forceps were applied in 7% (n=2) of the cases and caesarean section was required in 7% (n=2) of the cases. In Group II normal vaginal delivery, forceps application and caesarean section were observed in 83% (n=25), 7% (n=2) and 10% (n=3) of the cases, respectively. No significant difference was observed in the APGAR. Scores were taken at one, two, three and five minutes after the birth of the baby in both the groups (P>0.05) Fig. (3). Fig. (4) shows level of sedation (=/ <3) and degree of motor blockade (=/ >grade IV) observed, which was not significantly different when compared between the groups (P>0.05). In Group I, complications such as fetal bradycardia in 10% (n=3) and nausea (6.7% (n=2)) vomiting (3.3%.(n=1)), hypotension were present in 6.67% of the parturient. Complications in Group II included were nausea (6.7%, (n=2)), hypotension (3.7%,(n=2)) and dura puncture (3%,(n=1))in mother and fetal bradycardia in (7%) of the delivered babies. The difference in two groups was not statistically significant (P=0.123367, P>0.05) Dura puncture was not observed in any patients. Fig. (5).

Fig. (1). Distribution of parturient according to cervical dilatation in Group I & II. (P>0.05).

Table 2. Systolic and diastolic blood pressure of the parturient in Groups I & II. (*- P<0.05).
Time interval Systolic blood pressure
(In mm of Hg)
P-value Diastolic blood pressure
(In mm of Hg)
P-value
Group I Group II Group I Group II
0 min 120.2 118.73 0.681 75.8 73.93 0.4225
5 min 112.2 107.26 0.2092 72.66 70.86 0.2839
10 min 111.53 108.6 0.484 72.33 68.73 0.07148
15 min 114.26 109.33 0.3439 74.36 71.93 0.2787
30 min 114.33 108.33 0.1629 74.13 71.6 0.2242
60 min 111.33 106.4 0.1298 71.4 70.66 0.8682
120 min 111.13 106.86 0.2358 71.93 70.33 0.2677
180 min 112.7 106.2 0.09353 72.73 71.53 0.6197
240 min 110.4 105.86 0.2182 73.2 70.33 0.08562
300 min 109.66 105.33 0.2339 72.93 69.73 0.1383
360 min 109 104 0.1105 70.66 68.06 0.02057*
Fig. (2). Comparison of time for epidural top-up in Group I & II.( * P<0.05).

Fig. (3). APGAR score at 1,2,3 & 5 minutes in groups I & II. (P>0.05).

Table 3. Heart rate and VAS score of the parturient in Group I & II. ( *- P<0.05, **- P<0.01, ***- P<0.001.
Time Interval Heart Rate P-Value VAS Score P-Value
Group I Group II Group I Group II
0 min 103.86 98.73 0.1195 9.66 9.63 0.8213
5 min 98.46 92.2 0.06892 6.9 6.63 0.296
10 min 98.73 92 0.05972 2.1 2.4 0.3163
15 min 96.73 93.26 0.1707 1.1 1.06 0.8655
30 min 102.46 89.73 0.000314*** 0.83 0.7 0.6043
60 min 96.73 94.46 0.4204 1.13 1.16 0.8655
120 min 102.13 92.06 0.006593** 1.56 1.43 0.6624
180 min 95.2 93.06 0.4823 1.7 1.2 0.01927*
240 min 96.33 95.26 0.4418 0.96 0.9 0.8925
300 min 104.06 92.73 0.001216** 0.6 1.26 0.01984*
360 min 98.13 93.8 0.08038 1.5 1.6 0.6819
Fig. (4). Sedation and Bromage scale in Group I & II.(P>0.05).

Fig (5). Complications in mother and fetus of Group I & II. (P>0.05).

5 . DISCUSSION

Epidural analgesia is considered as a “Gold standard” technique and commonly accepted procedure for pain relief in labour. The use of epidural drugs such as ropivacaine is increased as it produces fewer cardiovascular complications compared with bupivacaine [9, 10]. The study was conducted to compare the efficacy of ropivacaine-fentanyl and bupivacaine-fentanyl in the alleviation of labour pain. Among studied parturients of both groups, the demographical characteristics such as age, weight, height were similar and most of the parturients of both groups were primigravida. These findings were comparable with previous reports [5, 10]. Tsen et al. concluded that early labour in parturients treated with spinal-epidural analgesia is associated with rapid cervical dilation [11]. The dilation of cervix may be due to decrease in mediators such as PG2α, responsible for uterine activity [12-14]. In this study, most of the cases of both the groups had 3-4cm of cervical dilation. Similar results were found in the study by Chora andHussain [15]. Bupivacaine possess potent cardiotoxicity, while ropivacaine has the advantage of differential sensory and motor blockade, without prominent cardio and neurotoxicity. It also stabilizes hemodynamic with minimal effect on heart rate and blood pressure [16]. An experimental study on rabbits by Bariskaner et al. showed that high doses of bupivacaine (5 and 10 mumol/kg) significantly reduce heart rate, systolic and diastolic blood pressure while 10mumol/kg ropivacaine can produce the same effect hence less cardio- depressant than bupivacaine [17]. This property of ropivacaine ensures the minimal effects on hemodynamic variables along with lesser cardiotoxicity profile as compared to bupivacaine, thus can be considered as agent of choice in patients with cardiovascular compromise /comorbidities so also in parturients especially with preeclampsia. In many previous reports, no difference was observed in systolic and diastolic blood pressure of parturients treated with ropivacaine and bupivacaine [5, 10, 15, 18]. In contrast, the study of Yadav and Jaiswal showed a significant difference in systolic blood pressure at 12 and 24-hour post anaesthesia wherein bupivacaine and fentanyl treated subjects significant decrease in diastolic blood pressure was observed at 15min, 30 min, 1hr, 2hr, 6hr, 12hr, and 24hr [19]. In our study, no significant difference was found in systolic blood pressure in both groups. However, a significant decrease in diastolic blood pressure was seen in Group II cases (P=0.020) when compared with Group I. The fluctuating values of blood pressure may be due to variations in the dose of drugs used and the time of blood pressure monitoring. Comparative studies with different volumes and concentrations of drugs such as 2ml 0.125% drug (bupivacaine or ropivacaine) with 5µg of fentanyl (2ml+0.125%+5µg), 20ml+0.125%+50µg, and 3ml+0.125 %+2µg showed no difference in heart rates [5, 10, 18]. In a study, 10ml 0.1% of drug with 2µg of fentanyl showed a significant difference in heart rates of parturients. Pain scores in bupivacaine and ropivacaine (0.1%) treated subjects in the first and second stages of labour showed comparable levels of analgesia [20]. In contrast with these findings, a significant difference was seen in VAS scores of both groups at 180 and 300 min with ropivacaine demonstrating better efficacy at 180 minutes and at 300 minutes. Bolus on-demand epidural doses may be the reason for lower VAS scores in patients. In this study, no significant difference in bolus requirement in both groups except 3rd top-up suggests equal efficacy in both groups. Similar results were shown by the study of Bawdaneet et al. using the same doses of the drugs [20]. Rate of vaginal delivery may get influenced by the type of epidural analgesia [10]. A combination of local anaesthetics with lower doses of opioids resulted in lower rates of instrumental deliveries [21, 22]. Chetty et al. in their study evaluated 0.125% vs 0.2% ropivacaine for epidural labor analgesia regarding sensory and motor block characteristics and found comparable maternal expulsive efforts, instrumental delivery and fetal outcome in both the groups [23]. Chethananand et al. evaluated efficacy of 0.0625% racemic bupivacaine and 0.1% of ropivacaine with 2 μg/ml of fentanyl and observed no significant difference in maternal satisfaction, mode of delivery, incidence of instrumentation and fetal outcome in two groups [24]. Thus studies by Chetty et al. and Chethananand et al. observed lesser incidences of instrumental deliveries and LSCS with 0.1%, 0.125%, 0.2% of ropivacaine and 0.625% of bupivacaine. Whereas, the study of Halpern et al. showed that bupivacaine was associated with an increased rate of motor block but the rate of spontaneous vaginal delivery was similar regardless of anaesthetic drug used. [25]. In our study, the rate of normal vaginal delivery was similar in both groups. There were no motor blockade instances in either group, possibly due to limited concentrations of anaesthetics used and these findings are similar to the study by Gündüz et al. [10] High rates of spontaneous delivery without incidence of motor blockade, may be due to low and titrated concentrations of the drug and the addition of opioids [10]. In both, the group incidences of adverse effects such as foetal bradycardia, nausea vomiting, sedation and hypotension were observed but similar which may be due to the use of opioids. The performance of bupivacaine and ropivacaine (0.1%) was found to be clinically very similar. There were no significant differences in pain score, sedation scores, motor blockade, blood pressure, mode of delivery and side effects. However, significant differences were found in heart rates at different time intervals. Limitations of the study are small sample sized. There is a need to add more cases to confirm the findings of our study statistically.

CONCLUSION

From our study we conclude that bupivacaine and ropivacaine were comparable in terms of quality of analgesia, hemodynamic stability, degree of motor blockade, requirement of top-up doses, incidence of instrumental delivery and side effects. Considering the safety profile and characteristic differential blockade, ropivacaine can be considered as a better alternative to bupivacaine for labour epidural analgesia.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

This prospective randomized study was performed at a tertiary care centre in Kolhapur, India, after approval by the Institutional Ethics and Review board (DYPMCK/PG-14/1721/15-16).

HUMAN AND ANIMAL RIGHTS

No animals were used in this research. All human research procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national), and with the Helsinki Declaration of 1975, as revised in 2013.

CONSENT FOR PUBLICATION

All patients participated on a voluntary basis and gave their informed consent.

AVAILABILITY OF DATA AND MATERIALS

Not applicable.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

We acknowledge the support of Department of Obstetrics and Gynaecology for directing cases for this study, providing data and help in analysis for the preparation of the manuscript.

REFERENCES

[1] Shnider SM, Abboud TK, Artal R, Henriksen EH, Stefani SJ, Levinson G. Maternal catecholamines decrease during labor after lumbar epidural anesthesia. Am J Obstet Gynecol 1983; 147(1): 13-5.
[2] Beigi NM, Broumandfar K, Bahadoran P, Abedi HA. Women’s experience of pain during childbirth. Iran J Nurs Midwifery Res 2010; 15(2): 77-82.
[3] Yerby M, Page L. Pain in childbearing: Key issues in management.2000; 17-42.
[4] Rao ZA, Choudhri A, Naqvi S, Ehsan-Ul-Haq . Walking epidural with low dose bupivacaine plus tramadol on normal labour in primipara. J Coll Physicians Surg Pak 2010; 20(5): 295-8.
[5] Zhao Q, Yan C, Fang B, et al. Efficacy and side effects comparison of bupivacaine and ropivacaine with fentanyl for labor analgesia under combined spinal and epidural analgesia. Int J Clin Exp Med 2018; 11(8): 8003-10.
[6] Chora I, Hussain A. Comparison of 0. 1% ropivacaine-fentanyl with 0.1% bupivacaine-fentanyl epidurally for labour analgesia. Advances in Anesthesiology 2014; 2014237034
[7] Ezberci M, Zencirci B, Öksüz H, Güven MA. Effects of general and epidural anaesthesia in newborn’sstres hormones, blood gases, and apgar scores in elective cesarean section. J Turk Obstet Gynecol 2005; 2: 284-9.
[8] Beilin Y, Halpern S. Focused review: Ropivacaine versus bupivacaine for epidural labor analgesia. Anesth Analg 2010; 111(2): 482-7.
[9] Lv BS, Wang W, Wang ZQ, et al. Efficacy and safety of local anesthetics bupivacaine, ropivacaine and levobupivacaine in combination with sufentanil in epidural anesthesia for labor and delivery: A meta-analysis. Curr Med Res Opin 2014; 30(11): 2279-89.
[10] Gündüz Ş, Yalçın SE, Karakoç G, Akkurt MÖ, Yalçın Y. Comparison of bupivacaine and ropivacaine in combination with fentanyl used for walking epidural anesthesia in labor. Turk J Obstet Gynecol 2017; 14(3): 170.
[11] Tsen LC, Thue B, Datta S, Segal S. Is combined spinal-epidural analgesia associated with more rapid cervical dilation in nulliparous patients when compared with conventional epidural analgesia? Anaesth 1999; 91(4): 920-5.
[12] Cambic CR, Wong CA. Labour analgesia and obstetric outcomes. Br J Anaesth 2010; 105(Suppl. 1): i50-60.
[13] Behrens O. GoeschenK, LuckHJ, FuchsAR. Effects of lumbar epidural analgesia onprostaglandin F2 alpha release and oxytocin secretion during labor. Prostaglandins 1993; 45: 285-96.
[14] Rahm VA. HallgrenA,HogbergH,HurtigI,OdlindV. Plasmaoxytocin levels in women during labor with or without epidural analgesia: A prospective study. Acta Obstet Gynecol Scand 2002; 81: 1033-9.
[15] Chora I, Hussain A. Comparison of 0.1% Ropivacaine-Fentanyl with 0.1% Bupivacaine-Fentanyl Epidurally for Labour Analgesia. Advances in Anesthesiology 2014.
[16] Wang H, Gao Q, Xu R, Dong W, Zhang Y, Fan J. The efficacy of ropivacaine and bupivacaine in the caesarean section and the effect on the vital signs and the hemodynamics of the lying-in women. Saudi J Biol Sci 2019; 26(8): 1991-4.
[17] Barişkaner H, Tuncer S, Ulusoy H, Dogan N. Effects of bupivacaine and ropivacaine on hemodynamic parameters in rabbits. Methods Find Exp Clin Pharmacol 2001; 23(2): 89-92.
[18] Reddy AC, Singh N, Rao PB, Ramachandran TR, George SK, Bhumika N. Randomized double blind controlled study of ropivacaine versus bupivacaine in combined spinal epidural anesthesia. Anaesth Pain Intensive Care 2019; 158-61.
[19] Yadava A, Jaiswal CK. Comparison of epidural bupivacaine-fentanyl and ropivacaine-fentanyl for postoperative analgesia in major abdominal surgeries-a prospective, randomised study. Indian Journal of Clinical Anaesthesia 2017; 4(3): 375-81.
[20] Bawdane KD, Magar JS, Tendolkar BA. Double blind comparison of combination of 0.1% ropivacaine and fentanyl to combination of 0.1% bupivacaine and fentanyl for extradural analgesia in labour. Journal of anaesthesiology, clinical pharmacology 2016; 32(1): 38-42.
[21] Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: A randomised controlled trial Lancet 2001; 358(9275): 19-23.
[22] Guo S, Li B, Gao C, Tian Y. Epidural analgesia with bupivacaine and fentanyl versus ropivacaine and fentanyl for pain relief in labor: A meta-analysis Medicine (Baltimore) 2015; 94(23)e880
[23] Chhetty YK, Naithani U, Gupta S, Bedi V, Agrawal I, Swain L. Epidural labor analgesia: A comparison of ropivacaine 0.125% versus 0.2% with fentanyl. J Obstet Anaesth Crit Care 2013; 3: 16-22.
[24] Chethanananda TN, Shashank MR, Madhu N, Achyutha J, Siva Kumar KV. Comparative efficacy of minimal concentration of racemic bupivacaine (0.0625%) with fentanyl and ropivacaine (0.1%) with fentanyl for epidural labor analgesia. Anesth Essays Res 2017; 11(3): 583-8.
[25] Halpern SH, Breen TW, Campbell DC, et al. A multicenter, randomized, controlled trial comparing bupivacaine with ropivacaine for labor analgesia. Anesthesiology 2003; 98(6): 1431-5.